- Home
- XP vs TECH Comparison
XP vs TECH Comparison
Compare XP & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XP
- TECH
- Stock Information
- Founded
- XP 2001
- TECH 1976
- Country
- XP Cayman Islands
- TECH United States
- Employees
- XP N/A
- TECH N/A
- Industry
- XP Investment Bankers/Brokers/Service
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XP Finance
- TECH Health Care
- Exchange
- XP Nasdaq
- TECH Nasdaq
- Market Cap
- XP 7.5B
- TECH 7.8B
- IPO Year
- XP 2019
- TECH 1989
- Fundamental
- Price
- XP $18.64
- TECH $46.78
- Analyst Decision
- XP Buy
- TECH Buy
- Analyst Count
- XP 6
- TECH 10
- Target Price
- XP $22.00
- TECH $73.44
- AVG Volume (30 Days)
- XP 7.9M
- TECH 2.2M
- Earning Date
- XP 05-20-2025
- TECH 05-07-2025
- Dividend Yield
- XP 3.48%
- TECH 0.68%
- EPS Growth
- XP 15.23
- TECH N/A
- EPS
- XP 1.51
- TECH 0.83
- Revenue
- XP $2,886,046,386.00
- TECH $1,208,770,000.00
- Revenue This Year
- XP $19.79
- TECH $7.16
- Revenue Next Year
- XP $12.65
- TECH $6.36
- P/E Ratio
- XP $12.35
- TECH $56.37
- Revenue Growth
- XP 9.27
- TECH 4.72
- 52 Week Low
- XP $10.82
- TECH $46.01
- 52 Week High
- XP $20.39
- TECH $83.96
- Technical
- Relative Strength Index (RSI)
- XP 72.66
- TECH 39.97
- Support Level
- XP $18.30
- TECH $46.05
- Resistance Level
- XP $19.85
- TECH $49.92
- Average True Range (ATR)
- XP 0.61
- TECH 2.20
- MACD
- XP 0.03
- TECH -0.04
- Stochastic Oscillator
- XP 72.20
- TECH 8.74
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.